Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Artiva Biotherapeutics (ARTV) Other Non Operating Income (2023 - 2025)

Artiva Biotherapeutics (ARTV) has disclosed Other Non Operating Income for 3 consecutive years, with $12000.0 as the latest value for Q4 2025.

  • For Q4 2025, Other Non Operating Income rose 340.0% year-over-year to $12000.0; the TTM value through Sep 2025 reached -$17000.0, up 98.39%, while the annual FY2024 figure was $157000.0, 19.49% down from the prior year.
  • Other Non Operating Income hit $12000.0 in Q4 2025 for Artiva Biotherapeutics, up from -$3000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $168000.0 in Q4 2023 and bottomed at -$977000.0 in Q3 2024.
  • Average Other Non Operating Income over 3 years is -$88909.1, with a median of -$3000.0 recorded in 2025.
  • Year-over-year, Other Non Operating Income plummeted 2054.0% in 2024 and then soared 340.0% in 2025.
  • Artiva Biotherapeutics' Other Non Operating Income stood at $168000.0 in 2023, then plummeted by 102.98% to -$5000.0 in 2024, then surged by 340.0% to $12000.0 in 2025.
  • According to Business Quant data, Other Non Operating Income over the past three periods came in at $12000.0, -$3000.0, and -$5000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.